| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |